1. Patients
Sixty-two (62) consecutive adult patients referred to our laboratory for a DTPA and a dimercapto-succinic acid (DMSA) scan initially entered the study after informed written consent. The study was approved by the ethical committee of our institution. The whole study protocol was completed in 55 patients. There were 4 rejections due to technical SPECT/CT errors and 3 patient no-shows on the 2nd day of the protocol (see below). Twenty-three (23) males and 32 females formed the final study population, aged 19–80 years old (56.3 ± 16.0), with a body surface area ranging from 1.40 to 2.26 Kg/m2 (1.85 ± 0.22). Forty-three (43) patients presented with hydronephrosis, 2 had a small kidney on ultrasound examination, 2 had uncontrolled hypertension, 2 were kidney donor candidates, and 4 had various other renal diseases. There was one patient with an ectopic kidney and another with a single kidney.
2. Study protocol
The study protocol included radioisotopic procedures taking place on two different days, separated by 48 hours, as follows:
Day 1: a) Conventional 99mTc-DTPA planar renogram for 30–40 min in posterior projection, with lasix given at 20 min, when necessary, followed in this case by another 20 min data acquisition; b) 99mTc-DMSA planar scan in anterior and posterior projection.
Day 3: c) 99mTc-DTPA dynamic SPECT renogram, corrected for attenuation via CT-derived attenuation maps [dSPECT(AC)]; d) 51Cr-ethylenediamine tetraacetic acid (EDTA) GFR measurement, by taking blood samples at 2 and 4 hours after tracer injection [12].
The radioisotopic procedures, radioactive agents used, initiation time of each procedure, injected tracer doses and procedures’ duration are presented in Table 1.
Table 1
Study protocol: radioisotopic procedures, time of initiation, radioactive agents administered, injected doses, elapsed time from injection and duration of each procedure.
|
Time
|
Tracer Injection
|
Dose
(MBq)
|
Elapsed time
|
Procedure
|
Duration
|
DAY 1
|
0
|
99mTc-DTPA
|
111–148
|
0
|
Planar renogram (lasix was given at 20 min in most cases)
|
20–40 min
|
|
1 hr
|
99mTc-DMSA
|
111–148
|
3 hrs
|
Planar images (in anterior and posterior projection)
|
4 min
|
DAY 3
|
0
|
99mTc-DTPA
|
333–444
|
0
|
CT + Dynamic SPECT
|
3 + 24 min
|
|
0
|
51Cr-EDTA
|
1.1
|
2 and 4 hrs
|
Blood sample collection
|
|
Either the Millenium VG or the Infinia 2-head gamma cameras (GE Healthcare), equipped with low-energy all-purpose collimators, were used for planar DTPA renogram and with high-resolution collimators for DMSA studies. The Millenium VG Hawkeye SPECT/CT system, with low-energy all-purpose collimators, was used for the dynamic SPECT renogram. This gamma camera model permits continuous SPECT acquisition, without time losses from one angular step to the other during gamma camera rotation. A CT scan was performed at the beginning of the imaging series. A number of CT slices were generated over a user-specified path length, which encompassed the area of the kidneys. Acquisition settings were 216° rotation of the X-ray tube; 10 mm slice step; 14 seconds slice time; 140 kV voltage; 2.5 mA current; 128×128 matrix size. A series of SPECT acquisitions ensued, using 1800 rotation of each camera head (3600 total) with body contour detection, 60 angular step, 64x64 pixels matrix size and energy window set at 140 kEV ± 30%, with various time per frame settings, for a total of 24 min. No lasix was given afterwards. As regards time per frame settings and duration of each SPECT, the dSPECT(AC) acquisition protocol is detailed in Fig. 1.
2. Data processing
Data processing of the conventional planar renogram included the construction of renographic curves and the calculation of various curve parameters. Among these and for the purpose of simplicity, a) the time to peak activity (TTP), b) split renal function (SRF), c) the normalized residual activity ratio at 20 minutes (NORA20) and d) GFR estimation were chosen for comparison with dSPECT(AC). Whenever TTP exceeded 20 minutes then the value 20 was assigned to this parameter. Renal activity at 2 to 3 minutes post injection was used for the calculation of SRF with both techniques. NORA20 is the ratio of renal activity at 20 minutes post injection divided by the 2-min activity [13]. GFR was calculated according to Gates’ method [3].
The tomographic reconstruction of raw dSPECT(AC) data was accomplished on a “Xeleris 3” workstation (GE Healthcare), by iterative algorithm (2 iterations, 10 subsets) and using Butterworth post-filtering (order 5, with the cut-off set at 0.35 of Nyquist frequency). The CT-created attenuation map was used for attenuation correction of the entire dynamic SPECT series. CT and SPECT slices in transaxial, coronal and sagittal planes were viewed together to determine adequate SPECT-CT co-registration. CT images were examined for potentially useful anatomic information (renal cysts, renal pelvis or ureter dilation, stones, etc.). Figure 2 presents an example.
The reconstructed data were converted into DICOM format and transferred to the “Image J” software [14], which was downloaded on a PC for further processing. Regions of interest (ROIs) surrounding renal parenchyma were manually drawn in consecutive transaxial SPECT slices on the 3rd SPECT, representing renal activity at 2 to 3 minutes post injection. The corresponding CT slices were inspected simultaneously, in order to aid ROI creation. Afterwards, this ROI set was copied on the whole SPECT series. Renographic curves were created in an xlsx worksheet, after inserting the numerical data obtained from “Image J”. TTP, SRF and NORA20 were calculated from the renographic curves. Similar to the method proposed be Gates [3], GFR estimation relied on renal activity at 2–3 minutes post-injection as a fraction of injected activity. For injected activity measurement, the syringe before and after tracer administration was imaged on the gamma camera by the SPECT/CT technique and the net activity was calculated.
The geometric mean of measured renal activity in anterior and posterior projection in 99mTc-DMSA images served as the reference method for SRF. 51Cr-EDTA served as the reference method for GFR.
Four Nuclear Medicine physicians (MS, NP, TS and DJA of the authors) were involved in the interpretation of planar and dSPECT(AC) studies. Interpretation inconsistencies were resolved by consensus.
3. Statistical analysis
Numerical data were expressed as the mean ± standard deviation (sd). The paired student’s t-test or the Wilcoxon signed-rank test, as appropriate, was used for the comparison of numerical parameters. The level of significance (p) was set below 0.05. The Pearson’s coefficient was used to express the correlation of numerical data series. The Bland-Altman analysis was implemented for the GFR estimation by the tested techniques in comparison with the reference method.